Browse Drug Recalls

3,394 FDA drug safety recalls.

FDA Drug Recall Enforcement Database

Browse 3,394 FDA drug recall enforcement actions. Each entry includes the product description, reason for recall, classification (Class I through III based on severity), recalling firm, and distribution details. Use the filters below to search by year, classification, state, or keyword.

Drug Safety Recalls

Browse 3,394 FDA drug recalls.

Clear
DateProductReasonClassFirm
Jan 13, 2025 Duloxetine Delayed-Release Capsules USP, 20 mg, packaged in a) 30 Unit Doses ... CGMP Deviations: presence of Nitrosamine Drug Substances Related Impurity (NDSRI), N-Nitroso-Dulo... Class II The Harvard Drug Group LLC dba Major Pharmaceut...
Dec 30, 2024 Duloxetine Delayed-Release Capsules USP 20 mg, 60 count bottles, Rx only, Dis... CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit. Class II Rising Pharma Holding, Inc.
Dec 30, 2024 Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30) and b) 1000... CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit. Class II Rising Pharma Holding, Inc.
Dec 30, 2024 Duloxetine Delayed-Release Capsules USP 30 mg, a) 30 count (NDC 57237-018-30)... CGMP Deviations; Presence of N-nitroso-duloxetine impurity above recommended interim limit. Class II Rising Pharma Holding, Inc.
Dec 23, 2024 First Aid Beauty Ultra Repair Cream, colloidal oatmeal 0.5%, Coconut Vanilla,... CGMP Deviations; product intended for quarantine was inadvertently distributed Class II First Aid Beauty Ltd
Dec 18, 2024 medroxyPROGESTERone Acetate Injectable Suspension, USP, 150mg per mL, Rx only... CGMP Deviations Class II Eugia US LLC
Dec 12, 2024 Dabigatran Etexilate, 75 mg capsules, 60-count bottles, Rx Only, Manufactured... CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit Class II Ascend Laboratories, LLC
Dec 12, 2024 Dabigatran Etexilate, 150mg capsules, 60-count bottles, Rx Only, Manufactured... CGMP Deviations: Presence of N-nitroso-Dabigatran impurity above recommended interim limit Class II Ascend Laboratories, LLC
Dec 11, 2024 chlorproMAZINE Hydrochloride Tablets, USP, 25 mg, 100-count bottle, RX only, ... CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per... Class II Glenmark Pharmaceuticals Inc., USA
Dec 11, 2024 chlorproMAZINE Hydrochloride Tablets, USP, 10mg, 100-count bottle, RX only, M... CGMP Deviations: N-Nitroso-Desmethyl Chlorpromazine impurity (NNDCI) were found to be failing per... Class II Glenmark Pharmaceuticals Inc., USA
Dec 6, 2024 Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottles... CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit. Class II Amerisource Health Services LLC
Dec 6, 2024 Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx Only, 90-count bottles (N... CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit. Class II Breckenridge Pharmaceutical, Inc
Dec 6, 2024 Nebivolol Tablets, 2.5. mg, 30-count bottles, Rx only, Distributed by: Aurobi... CGMP Deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso Nebiv... Class II Aurobindo Pharma USA Inc
Dec 6, 2024 Duloxetine Delayed-Release Capsules USP, 60 mg, Rx only, 30 count bottles, Ma... CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit. Class II Amerisource Health Services LLC
Dec 6, 2024 Duloxetine Delayed-Release Capsules USP, 30 mg, Rx only, 30 count bottles, Ma... CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit. Class II Amerisource Health Services LLC
Dec 6, 2024 Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, 90 count bottles, M... CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit. Class II Amerisource Health Services LLC
Dec 6, 2024 Duloxetine Delayed-Release Capsules, USP, 30mg, Rx Only, 90-count bottles (ND... CGMP Deviations: presence of N-nitroso-duloxetine impurity above FDA recommended interim limit. Class II Breckenridge Pharmaceutical, Inc
Dec 4, 2024 DULoxetine DR USP, 30 mg, 90-count bottle, Rx Only, Packaged by: PD Rx Pharma... CGMP Deviations: the presence of a Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso... Class II PD-Rx Pharmaceuticals, Inc.
Dec 2, 2024 Duloxetine Delayed-Release Capsules, 60 mg, a) 30 count blister cards (NDC 70... CGMP Deviations; presence of N-nitroso-duloxetine impurity above recommended interim limit. Class II RemedyRepack Inc.
Nov 27, 2024 Cinacalcet Tablets, 30 mg, 30-count bottle, Rx only, Manufactured for: AvKARE... CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinac... Class II AvKARE
Nov 27, 2024 Cinacalcet Tablets, 90 mg, 30-count bottle, Rx only, Manufactured for: AvKARE... CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinac... Class II AvKARE
Nov 27, 2024 Cinacalcet Tablets, 60 mg, 30-count bottle, Rx only, Manufactured for: AvKARE... CGMP deviations: Presence of Nitrosamine Drug Substance Related Impurity (NDSRI), N-Nitroso-Cinac... Class II AvKARE
Nov 22, 2024 VCF, Vaginal Contraceptive Gel, Birth Control, 10 Pre-filled Applicators, Net... CGMP deviations: out of specifications for assay Class II Apothecus Pharmaceutical Corp.
Nov 22, 2024 10 Irregular Pigmentation, Accelerator, Pigment Fading Activator, Only Your R... CGMP Deviations: Inconsistency in the water systems. Class II Generitech Corporation
Nov 19, 2024 Duloxetine Delayed-Release Capsules USP, 20 mg, 60 count bottles, Rx only, Di... CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit Class II Rising Pharma Holding, Inc.
Nov 19, 2024 Duloxetine Delayed-Release Capsules USP, 30 mg, a) 30 count (NDC 57237-018-30... CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit Class II Rising Pharma Holding, Inc.
Nov 19, 2024 Duloxetine DR Capsules USP 60 mg, a) 30 count (NDC 57237-019-30), b) 90 count... CGMP Deviations: Presence of N-nitroso-duloxetine impurity above recommended interim limit Class II Rising Pharma Holding, Inc.
Nov 14, 2024 Patterson Dental, Patterson Topical Anesthetic Gel, Benzocaiine, 1 oz. (30 ml... CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of th... Class II Keystone Industries
Nov 14, 2024 Burkhart, Topical Anesthetic Gel, Benzocaine 20%, Gluten Free, 1 FL. OZ (30 m... CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of th... Class II Keystone Industries
Nov 14, 2024 Duloxetine Delayed-Release Capsules, USP, 20 mg, Rx only, 60 count bottles, M... CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit Class II Amerisource Health Services LLC
Nov 14, 2024 UMARY ACID HYALURONIC, 850 MG CAPLETS, 30-count bottle, UPC7502265120323 cGMP Deviations: the firm initiated a recall after notification from the distributor that product... Class II MXBBB
Nov 14, 2024 Ipana, 20% Benzocaine Topical Gel, 28g, Maxill Inc., St Thomas ON Canada. CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of th... Class II Keystone Industries
Nov 14, 2024 M&S Dental Supply Co LLC., Topical Anesthetic Gel, Benzocaine 20%, Net Wt. 1 ... CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of th... Class II Keystone Industries
Nov 14, 2024 Pearson Quality, Topical Anesthetic Gel, 20% Benzocaine, For Professional Use... CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of th... Class II Keystone Industries
Nov 14, 2024 Primo, Topical Anesthetic gel, Benzocaine 20%, Net Content: 1 oz. (30g), Glut... CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of th... Class II Keystone Industries
Nov 14, 2024 Health-Tec, Topical Anesthetic Gel, Benzocaine 20%, Made in USA, 1 FL. OZ (29... CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of th... Class II Keystone Industries
Nov 14, 2024 Kirkland Severe Cold & Flu Plus Congestion: Day - 112 coated caplets blister ... CGMP Deviations: Released product should have been rejected. Class II LNK International, Inc.
Nov 14, 2024 Dental City, Topical Anesthetic Gel, Benzocaine 20%, Net Content: 1 oz. (30 m... CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of th... Class II Keystone Industries
Nov 14, 2024 safco, SensiCaine Ultra, Topical Anesthetic Gel, Contains 20% Benzocaine, 1 o... CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of th... Class II Keystone Industries
Nov 14, 2024 Duloxetine Delayed-Release Capsules, USP, 30 mg, Rx only, a) 30 count (NDC 68... CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit Class II Amerisource Health Services LLC
Nov 14, 2024 Quala Dental Products, Topical Anesthetic Gel, Contains 20% Benzocaine, Net C... CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of th... Class II Keystone Industries
Nov 14, 2024 Henry Schein, Benzo-Jel, Topical Anesthetic Gel, 20% Benzocaine, 1 fl. oz. (2... CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of th... Class II Keystone Industries
Nov 14, 2024 Duloxetine Delayed-Release Capsules, USP, 60 mg, Rx only, 1,000 count bottle,... CGMP Deviations: Presence of N-nitroso-duloxetine impurity above the recommended interim limit Class II Amerisource Health Services LLC
Nov 14, 2024 Gelato, Benzocaine 20% Topical Gel Anesthetic Gel, Net Wt. 1 oz. (30ml), Manu... CGMP deviations: the bulk product was rejected by the Quality Unit after routine inspection of th... Class II Keystone Industries
Nov 13, 2024 Kissable Diabetics Foot Cream, NET WT 4 oz (113 g) per tube, Manufactured By:... CGMP Deviations: lack of adequate release testing. Class II Brands International Corporation
Nov 11, 2024 Vitamin D3, 25 mcg, 1 tablet in blister card-foils, 100-count unit dose box, ... cGMP Deviations: Observations were made that some blister card-foils were separating from the bli... Class II Safecor Health, LLC
Nov 11, 2024 Vitamin B1, 100 mcg, 1 tablet in blister card-foils, 100-count unit dose box,... cGMP Deviations: Observations were made that some blister card-foils were separating from the bli... Class II Safecor Health, LLC
Nov 11, 2024 Docusate Sodium 250 mg, 1 Softgel in blister card-foils, 100-count unit dose ... cGMP Deviations: Observations were made that some blister card-foils were separating from the bli... Class II Safecor Health, LLC
Nov 11, 2024 Calcium Carbonate Chewable 500 mg, 1 tablet in blister card-foils, 100-count ... cGMP Deviations: Observations were made that some blister card-foils were separating from the bli... Class II Safecor Health, LLC
Nov 11, 2024 Aspirin Chewable tablet 81 mg, 1 tablet in blister card-foils, 100-count unit... cGMP Deviations: Observations were made that some blister card-foils were separating from the bli... Class II Safecor Health, LLC

Frequently Asked Questions

When a drug safety issue is identified — through FDA inspections, laboratory testing, adverse event reports, or manufacturer quality checks — the responsible company issues a recall to remove the affected products from the market. Pharmacies pull the product from shelves, and consumers are advised to contact their healthcare provider for alternatives.

The leading causes include cGMP deviations, impurity contamination (including nitrosamines like NDMA), failed dissolution or stability testing, sterility issues, potency problems, labeling errors, and foreign particle contamination.

Use the search and filter tools on this page to look up specific medications, active ingredients, or manufacturers. Each recall entry includes the product description, lot numbers, and distribution details.